Literature DB >> 31548298

Enhancing shared decision making about discontinuation of antidepressant medication: a concept-mapping study in primary and secondary mental health care.

Carolien Wentink1, Marloes J Huijbers1, Peter Lbj Lucassen2, Annoek van der Gouw3, Cornelis Kramers4, Jan Spijker5, Anne Em Speckens1.   

Abstract

BACKGROUND: The apparent rise of antidepressant use seems to be explained to a large extent by an increase in long-term use. Both professionals and patients appear reluctant to discontinue antidepressant medication (ADM). It is not known what factors determine this reluctance. AIM: This study aimed to identify factors that enable the shared decision-making process about discontinuation of ADM between long-term users and their GPs. DESIGN AND
SETTING: Concept-mapping study of a purposive sample of both patients and professionals from primary and secondary mental health care in the Netherlands.
METHOD: Concept mapping was used to conceptualise and structure the topics relevant to the discontinuation process from the perspective of both patients and professionals. Participants generated topics in brainstorming sessions and subsequently prioritised and sorted them. Multidimensional scaling and hierarchical cluster analyses were used for the cluster topics.
RESULTS: Thirty-seven patients and 27 professionals generated 50 separate topics. Hierarchical cluster analysis revealed six clusters of topics: 'Process of discontinuation', 'Expectations', 'Professional guidance', 'Current use', 'Environment', and 'Side effects'. Patients and professionals came up with largely similar topics. Nevertheless, a difference was found between these groups regarding the perceived importance of professional guidance.
CONCLUSION: This study yielded an informed selection of the topics that seem most important to discuss when considering whether to discontinue ADM. As perspectives of both patients and professionals were combined, the topics may provide patients and GPs with a broader and more balanced scope of factors to consider, and thus facilitate a better shared decision-making process. © British Journal of General Practice 2019.

Entities:  

Keywords:  antidepressive agents; decision making; deprescriptions; general practice

Year:  2019        PMID: 31548298      PMCID: PMC6758920          DOI: 10.3399/bjgp19X706001

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  24 in total

1.  National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey.

Authors:  Ramin Mojtabai; Mark Olfson
Journal:  J Clin Psychiatry       Date:  2014-02       Impact factor: 4.384

2.  Better safe than sorry--why patients prefer to stop using selective serotonin reuptake inhibitor (SSRI) antidepressants but are afraid to do so: results of a qualitative study.

Authors:  Pietje M Verbeek-Heida; Edith F Mathot
Journal:  Chronic Illn       Date:  2006-06

3.  Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study.

Authors:  Raymond Noordam; Nikkie Aarts; Katia M Verhamme; Miriam C M Sturkenboom; Bruno H Stricker; Loes E Visser
Journal:  Eur J Clin Pharmacol       Date:  2015-01-06       Impact factor: 2.953

Review 4.  An overview of concept mapping in Dutch mental health care.

Authors:  Udo Nabitz; Carlijn van Randeraad-van der Zee; Ineke Kok; Marja van Bon-Martens; Peter Serverens
Journal:  Eval Program Plann       Date:  2016-09-03

Review 5.  Presenting risk information--a review of the effects of "framing" and other manipulations on patient outcomes.

Authors:  A Edwards; G Elwyn; J Covey; E Matthews; R Pill
Journal:  J Health Commun       Date:  2001 Jan-Mar

6.  Developing a quality criteria framework for patient decision aids: online international Delphi consensus process.

Authors:  Glyn Elwyn; Annette O'Connor; Dawn Stacey; Robert Volk; Adrian Edwards; Angela Coulter; Richard Thomson; Alexandra Barratt; Michael Barry; Steven Bernstein; Phyllis Butow; Aileen Clarke; Vikki Entwistle; Deb Feldman-Stewart; Margaret Holmes-Rovner; Hilary Llewellyn-Thomas; Nora Moumjid; Al Mulley; Cornelia Ruland; Karen Sepucha; Alan Sykes; Tim Whelan
Journal:  BMJ       Date:  2006-08-14

Review 7.  What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs.

Authors:  Judith H Hibbard; Jessica Greene
Journal:  Health Aff (Millwood)       Date:  2013-02       Impact factor: 6.301

8.  Side effects of antidepressants during long-term use in a naturalistic setting.

Authors:  Pierre M Bet; Jacqueline G Hugtenburg; Brenda W J H Penninx; Witte J G Hoogendijk
Journal:  Eur Neuropsychopharmacol       Date:  2013-05-30       Impact factor: 4.600

9.  Barriers and facilitators to discontinuing antidepressant use: A systematic review and thematic synthesis.

Authors:  Emma Maund; Rachel Dewar-Haggart; Samantha Williams; Hannah Bowers; Adam W A Geraghty; Geraldine Leydon; Carl May; Sarah Dawson; Tony Kendrick
Journal:  J Affect Disord       Date:  2018-10-17       Impact factor: 4.839

10.  Toward Minimum Standards for Certifying Patient Decision Aids: A Modified Delphi Consensus Process.

Authors:  Natalie Joseph-Williams; Robert Newcombe; Mary Politi; Marie-Anne Durand; Stephanie Sivell; Dawn Stacey; Annette O'Connor; Robert J Volk; Adrian Edwards; Carol Bennett; Michael Pignone; Richard Thomson; Glyn Elwyn
Journal:  Med Decis Making       Date:  2013-08-20       Impact factor: 2.583

View more
  5 in total

1.  Real world partnership with patients.

Authors:  Josie Solomon; Ruth Shelton; Sandy Taylor
Journal:  Br J Gen Pract       Date:  2019-09-26       Impact factor: 5.386

2.  The 'patient voice': patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition.

Authors:  Anne Guy; Marion Brown; Stevie Lewis; Mark Horowitz
Journal:  Ther Adv Psychopharmacol       Date:  2020-11-09

Review 3.  Barriers to discontinuing antidepressants in patients with depressive and anxiety disorders: a review of the literature and clinical recommendations.

Authors:  Willemijn Scholten; Neeltje Batelaan; Anton Van Balkom
Journal:  Ther Adv Psychopharmacol       Date:  2020-06-10

4.  Long-term antidepressant use in general practice: a qualitative study of GPs' views on discontinuation.

Authors:  Maria Donald; Riitta Partanen; Leah Sharman; Johanna Lynch; Genevieve A Dingle; Catherine Haslam; Mieke van Driel
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

5.  Discontinuing antidepressant medication after mindfulness-based cognitive therapy: a mixed-methods study exploring predictors and outcomes of different discontinuation trajectories, and its facilitators and barriers.

Authors:  Marloes J Huijbers; Carolien Wentink; Esther Simons; Jan Spijker; Anne Speckens
Journal:  BMJ Open       Date:  2020-11-11       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.